Gerardo Rosati

3.8k citations

112 papers · 1.7k indexed · 1 hit paper · h-index 20

Impact in

Oncology top 2%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
- Cancer Treatment and Pharmacology
Surgery top 5%
- Colorectal and Anal Carcinomas

Papers in

Oncology 84
- Colorectal Cancer Treatments and Studies 67
- Cancer Treatment and Pharmacology 30
- Colorectal Cancer Surgical Treatments 15
Pulmonary and Respiratory Medicine 51
- Gastric Cancer Management and Outcomes 34
- Lung Cancer Treatments and Mutations 13

Co-authors: Luigi Manzione Stefano Cordio Carmine Pinto C. Aschele Sara Lonardi Luca Boni L. Cionini A. Tagliagambe
Journals: Journal of Clinical Oncology (27 papers)Annals of Oncology (15 papers)Oncology (6 papers)Journal of Chemotherapy (3 papers)Journal of Geriatric Oncology (3 papers)
Partner nations: Italy United States Spain

In The Last Decade

Gerardo Rosati

107 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial 2011 · 535 citations

Peers

Countries citing papers authored by Gerardo Rosati

Since Specialization

Citations

This map shows the geographic impact of Gerardo Rosati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerardo Rosati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerardo Rosati more than expected).

Fields of papers citing papers by Gerardo Rosati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerardo Rosati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerardo Rosati. The network helps show where Gerardo Rosati may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerardo Rosati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerardo Rosati Line = papers co-authored together Gerardo Rosati links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review Journal of Clinical Medicine ·Michele Montrone, Gerardo Rosati, Vito Longo, Annamaria Catino, Raffaella Massafra, Annalisa Nardone, Francesco Pesola, Elisabetta Montagna, Ilaria Marech, Pamela Pizzutilo, Domenico Galetta	2023	8
2	An Overview of the Roles of CDK4/6 Inhibitors in Metastatic Breast Cancer Elderly Patients In Vivo ·Carmen Pacilio, Gerardo Rosati, Anna Crispo, Sabrina Bimonte, Francesca Di Rella, Francesco Nuzzo, Michelino De Laurentiis	2023	5
3	A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial Gastric Cancer ·Gerardo Rosati, Chiara Alessandra Cella, Luigi Cavanna, Carla Codecà, Michele Prisciandaro, Stefania Mosconi, Giovanna Luchena, Nicola Silvestris, Ilaria Bernardini, Rossana Casaretti, Federica Zoratto, D. Amoroso, A. Ciarlo, Sandro Barni, Stefano Cascinu, Cristina Davite, Alessandro Di Sanzo, Alessia Casolaro, Domenico Bilancia, Roberto Labianca	2022	4
4	NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study. PubMed ·Rossella De Luca, Carmine Volpe, Ornella Mistretta, Riccardo Paci, Giuseppe Ferrera, Caputo, Gerardo Rosati, Giuseppe Cicero	2021	3
5	399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trial Annals of Oncology ·Gerardo Rosati, Francesca Galli, Sara Lonardi, Katia Dotti, Monica Ronzoni, Maria Giulia Zampino, Maria Banzi, Valeria Pusceddu, Felice Pasini, Silvia Bozzarelli, Nicoletta Pella, Carla Codecà, Vincenzo Montesarchio, Andrea Mambrini, Alfonso De Stefano, L. Ciuffreda, Sara Elena Rebuzzi, Domenico Bilancia, Roberto Labianca	2020	1
6	Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC). Journal of Clinical Oncology ·Timothy Iveson, Alberto F. Sobrero, Takayuki Yoshino, Ioannis Sougklakos, Fang‐Shu Ou, Jeffery P. Meyers, Qian Shi, Mark Saunders, Roberto Labianca, Takeharu Yamanaka, Ioannis Boukovinas, Niels Henrik Holländer, Valter Torri, Kentaro Yamazaki, Vassilis Georgoulias, Sara Lonardi, Andrea Harkin, Gerardo Rosati, James Paul	2019	27
7	Optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC): the multicentre, randomized phase 3 study OBELICS Annals of Oncology ·Antonio Avallone, Guglielmo Nasti, Gerardo Rosati, Chiara Carlomagno, Carmela Romano, Domenico Bilancia, Alfonso De Stefano, Alessandro Ottaiano, Antonio Cassata, Francesco Bianco, Paolo Del Rio, Francesco Izzo, Lucrezia Silvestro, Salvatore Tafuto, Elena Di Gennaro, Secondo Lastoria, Ciro Gallo, Federica Perrone, Alfredo Budillon, Maria Carmela Piccirillo	2017	1
8	HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives Oncotarget ·V. Fanotto, Elena Ongaro, Karim Rihawi, Antonio Avallone, Nicola Silvestris, Lorenzo Fornaro, Enrico Vasile, Lorenzo Antonuzzo, Francesco Leone, Gerardo Rosati, Francesco Giuliani, Roberto Bordonaro, Mario Scartozzi, Giovanna De Maglio, Francesca Negri, Gianpiero Fasola, Giuseppe Aprile	2016	26
9	Phase II open-label single-arm study of pre-operative panitumumab and external pelvic radiotherapy (RTE) in locally advanced rectal cancer (LARC) patients (pts) (RaP/STAR-03 Study) Annals of Oncology ·Carmine Pinto, M. Di Bisceglie, Francesca Di Fabio, Anna Maria Bochicchio, Tiziana Pia Latiano, Stefano Cordio, Gerardo Rosati, C. Aschele, Antonella Marino, Francesca Bergamo, Sara Bustreo, Giovanni Luca Frassineti, Fortunato Ciardiello, S. Giaquinta, Daniela Baldari, Luca Boni	2016	1
10	Impact of age, ECOG PS and type of treatment on progression-free survival and overall survival in second-line therapy for advanced gastric cancer: analysis on 709 cases Annals of Oncology ·V. Fanotto, Caterina Fontanella, Mario Uccello, G. Pasquini, Silvia Bozzarelli, Francesco Leone, Marco Russano, Gerardo Rosati, Giovanni Tomasello, Nicola Silvestris, Filippo Pietrantonio, Isabella Paladina, E.S. Lutrino, Davide Melisi, Lorenzo Antonuzzo, Chiara Caparello, Stefano Cordio, Virginia Rotella, Lorenza Rimassa, Giuseppe Aprile	2015	1
11	Association with programmed death ligand-1 (PDL-1) expression and Helicobacter Pylori infection in patients with non-diffuse type gastric carcinoma Annals of Oncology ·Maria Di Bartolomeo, Alessandro Pellegrinelli, Roberto Iacovelli, Filippo Pietrantonio, Rosa Berenato, M. Caporale, Monica Niger, Maria Aurelia Barbera, Roberto Labianca, A. Martoni, Gerardo Rosati, Donato Nitti, C. Boni, D. Amadori, Maurizio Cantore, Filippo de Braud, Emilio Bajetta	2015	2
12	Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial Journal of Clinical Oncology ·C. Aschele, L. Cionini, Sara Lonardi, Carmine Pinto, Stefano Cordio, Gerardo Rosati, Salvatore Artale, A. Tagliagambe, Giovanni Ambrosini, Paola Rosetti, Andrea Bonetti, Maria Emanuela Negru, Maria Chiara Tronconi, Gabriele Luppi, Giovanni Silvano, Domenico Corsi, Anna Maria Bochicchio, Germana Chiaulon, Maurizio Gallo, Luca Boni Hit paper breakdown →	2011	535
13	Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study Supportive Care in Cancer ·Paul J. Hesketh, Oliver Wright, Gerardo Rosati, Mark W. Russo, Jeremey Levin, Stephen Lane, Vladimir Moiseyenko, Pierre Dubé, М. В. Копп, Anatoly Makhson	2011	26
14	Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study) Annals of Oncology ·Carmine Pinto, Francesca Di Fabio, Evaristo Maiello, Sara Pini, Tiziana Pia Latiano, C. Aschele, Carlo Garufi, Anna Maria Bochicchio, Gerardo Rosati, Giuseppe Aprile, S. Giaquinta, Valter Torri, Alberto Bardelli, María Gión, Andrea Martoni	2011	46
15	Discontinuation of bevacizumab and FOLFIRI administered up to a maximum of 12 cycles as first-line therapy for metastatic colorectal cancer: a retrospective Italian study Investigational New Drugs ·Gerardo Rosati, Stefano Cordio, Giuseppe Aprile, Alfredo Butera, Antonio Avallone, Giuseppe Di Lucca, F. De Pauli, Héctor Soto Parrà, Giorgio Reggiardo, Roberto Bordonaro	2011	7
16	Phase II Trial of Oxaliplatin and Tegafur/Uracil and Oral Folinic Acid for Advanced or Metastatic Colorectal Cancer in Elderly Patients Oncology ·Gerardo Rosati, Stefano Cordio, Aniello Tucci, Giuseppina Blanco, Roberto Bordonaro, Giorgio Reggiardo, Luigi Manzione	2005	36
17	A Phase II Study of Irinotecan Alternated with a Weekly Schedule of Oxaliplatin, High-Dose Leucovorin and 48-Hour Infusion 5-Fluorouracil in Patients with Advanced Colorectal Cancer Oncology ·Gerardo Rosati, Aniello Tucci, Antonio Rinaldi, Diodoro Colarusso, Carmine Pizza, Giorgio Reggiardo, Luigi Manzione	2004	6
18	First-Line Chemotherapy With Fluorouracil and Folinic Acid for Advanced Colorectal Cancer in Elderly Patients Journal of Clinical Gastroenterology ·Bruno Daniele, Gerardo Rosati, Rosa Tambaro, Alessandro Ottaiano, Ermelinda De Maio, Sandro Pignata, Rosario Vincenzo Iaffaioli, Antônio Rossi, Luigi Manzione, Ciro Gallo, Federica Perrone	2003	26
19	Subcutaneous Granulocyte-Macrophage Colony-Stimulating Factor in Mucositis Induced by an Adjuvant 5-Fluorouracil plus Leucovorin Regimen Oncology ·Antônio Rossi, Gerardo Rosati, Diodoro Colarusso, Luigi Manzione	2003	10
20	Hyperthyroidism as a precipitating factor of amyotrophic lateral sclerosis: a case report. Institutional Research Information System University of Ferrara (University of Ferrara) ·Gerardo Rosati, E Govoni, I. Aiello, Enrico Granieri, R. Tola, Bragaglia Mm	1980	2

About Gerardo Rosati

Gerardo Rosati is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Pathology and Forensic Medicine and Surgery, having authored 112 papers that have together received 1.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (67 papers), Gastric Cancer Management and Outcomes (34 papers), Cancer Treatment and Pharmacology (30 papers), Colorectal and Anal Carcinomas (19 papers), Genetic factors in colorectal cancer (17 papers), Colorectal Cancer Surgical Treatments (15 papers), Lung Cancer Treatments and Mutations (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (11 papers). The work is most often cited by research in Oncology (1.4k citations), Surgery (893 citations), Pulmonary and Respiratory Medicine (482 citations), Hepatology (117 citations) and Pathology and Forensic Medicine (180 citations). Gerardo Rosati has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Luigi Manzione, Stefano Cordio, Carmine Pinto, C. Aschele, Sara Lonardi, Luca Boni, L. Cionini, A. Tagliagambe, Paola Rosetti and Salvatore Artale. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncology, Journal of Chemotherapy and Journal of Geriatric Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact